Chelsea Bartley, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 109 Homewood Blvd, Glasgow, KY 42141 Phone: 270-651-6126 |
William Foster, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 109 Homewood Blvd, Glasgow, KY 42141 Phone: 270-651-6126 |
Mr. Jeffrey Couch, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 300 Westwood St, Glasgow, KY 42141 Phone: 270-651-9131 |
Emily Staples, MS, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 300 Westwood St, Glasgow, KY 42141 Phone: 270-651-9131 |
Emily Taylor Porter, OTR/L Occupational Therapist - Physical Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 1301 N Race St, Glasgow, KY 42141 Phone: 270-651-4444 |
Sarah Elizabeth Jennings Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 130 Slash Rd, Glasgow, KY 42141 Phone: 270-646-6309 |
H2 Health Occupational Therapist Medicare: Medicare Enrolled Practice Location: 1410 N Race St, Glasgow, KY 42141 Phone: 270-651-7882 Fax: 270-651-7883 |
Ms. Karin J Foster, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1301 N Race St, Glasgow, KY 42141 Phone: 270-651-4844 Fax: 270-651-4808 |
News Archive
InSightec Ltd., the global leader in MR guided focused ultrasound technology and the only company to receive FDA approval for its ExAblate(R) system for treating uterine fibroids, announced today that its ExAblate(R) system has been used for the first time for the treatment of prostate cancer patients.
Healthcare surveys specialist, CFEP Surveys, has today announced the availability of a new survey to gather and analyse patient feedback on telephone and video consultations.
Americans United for Life Action President and CEO Dr. Charmaine Yoest said, "The passage of this amendment is a victory for the pro-life Americans across this country who have flooded Congress this week with the message that abortion does not belong in health care. The bipartisan effort that led to its passage, under the leadership of Congressmen Bart Stupak and Joe Pitts, is a step toward a future where both political parties defend Life."
Access to targeted therapies for lung cancer depends on accurate identification of patients' biomarkers through molecular testing, but survey results published today in the Journal of Thoracic Oncology suggest that many international clinicians are unaware of evidence-based guidelines that support the use of molecular testing.
› Verified 9 days ago